Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{196136,
        author = {Mr. N. Jaya Kumar},
        title = {Impact Of Mergers and Acquisitions on Financial Performance in The Pharmaceutical Industry: Evidence from India},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {no},
        pages = {70-73},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=196136},
        abstract = {Mergers and acquisitions (M&A) have become central strategic instruments in the pharmaceutical industry, particularly in volatile and innovation-driven environments. This study evaluates the impact of M&A on the financial performance of selected Indian pharmaceutical firms using a longitudinal pre- and post-merger framework. The study analyzes ten years of financial data (five years before and five years after merger) for six major firms. Profitability, financial risk, and operational efficiency were assessed using paired sample t-tests. The results indicate statistically significant improvements in profitability and efficiency, alongside a moderate increase in leverage. The findings support synergy-based explanations of merger outcomes while emphasizing the importance of disciplined financial management. The study contributes to emerging market merger literature and offers strategic implications for corporate leadership.},
        keywords = {Mergers and Acquisitions; Financial Performance; Pharmaceutical Industry; Paired t-test; Emerging Markets.},
        month = {March},
        }